Page last updated: 2024-10-24

positive regulation of glomerulus development

Definition

Target type: biologicalprocess

Any process that increases the rate, frequency or extent of glomerulus development, the progression of the glomerulus over time from its initial formation until its mature state. The glomerulus is a capillary tuft surrounded by Bowman's capsule in nephrons of the vertebrate kidney. [GOC:dph, GOC:tb, GOC:yaf]

Positive regulation of glomerulus development is a complex and essential biological process that ensures the proper formation and function of the glomerulus, the filtering unit of the kidney. This process involves a tightly orchestrated interplay of various signaling pathways, transcription factors, and cell types.

The glomerulus is composed of three major cell types: podocytes, mesangial cells, and endothelial cells. Each cell type contributes significantly to the development and function of the glomerulus.

1. **Podocytes** are highly specialized epithelial cells that form the filtration barrier of the glomerulus. Their foot processes interdigitate with each other, creating a complex network of filtration slits that prevent the passage of large molecules from the blood into the urine.

2. **Mesangial cells** are located within the glomerular tuft and contribute to the structural integrity of the glomerulus. They also play a role in regulating blood flow through the glomerulus and in clearing debris from the filtration barrier.

3. **Endothelial cells** form the inner lining of the glomerular capillaries, allowing for the exchange of nutrients and waste products between the blood and the glomerular filtrate.

The positive regulation of glomerulus development involves a series of events that initiate and promote the formation of these cell types and their interactions.

**Key events in positive regulation of glomerulus development include:**

* **Induction of glomerular progenitors:** The formation of the glomerulus begins with the induction of glomerular progenitors from the metanephric mesenchyme. This process is regulated by signaling molecules, such as Wnt, BMP, and FGF, which act in a coordinated manner to promote the expression of genes involved in glomerular development.

* **Formation of the vascular tuft:** Once glomerular progenitors are induced, they begin to differentiate into podocytes, mesangial cells, and endothelial cells. These cells then assemble into a vascular tuft, the core structure of the glomerulus. The formation of the vascular tuft is driven by the growth and branching of capillaries, a process that is regulated by vascular endothelial growth factor (VEGF).

* **Podocyte differentiation and maturation:** Podocytes undergo a complex series of differentiation and maturation events to acquire their specialized functions. This process is regulated by a variety of signaling pathways and transcription factors, including WT1, Pax2, and NPHS1.

* **Formation of the filtration barrier:** The filtration barrier of the glomerulus is formed by the interaction of podocytes, mesangial cells, and endothelial cells. The foot processes of podocytes interdigitate with each other, creating a complex network of filtration slits that prevent the passage of large molecules from the blood into the urine. The basement membrane of the glomerulus, a thin layer of extracellular matrix, provides additional support for the filtration barrier.

* **Regulation of blood flow:** The glomerulus is highly vascularized, and blood flow through the glomerulus is tightly regulated. Mesangial cells play a key role in regulating blood flow by contracting and relaxing, which alters the size of the filtration surface.

* **Clearance of debris:** The glomerulus is constantly exposed to debris and pathogens that can accumulate in the filtration barrier. Mesangial cells play a role in clearing this debris by phagocytosis and by secreting inflammatory mediators that attract immune cells.

**Disruption of positive regulation of glomerulus development can lead to a variety of kidney diseases, including:**

* **Glomerulonephritis:** Inflammation of the glomerulus, which can damage the filtration barrier and lead to proteinuria, hematuria, and kidney failure.

* **Diabetic nephropathy:** Damage to the glomerulus caused by high blood sugar levels, which can lead to proteinuria, hypertension, and kidney failure.

* **Congenital nephrotic syndrome:** A group of genetic disorders that affect the development of the glomerulus, leading to severe proteinuria and kidney failure.

**In summary, positive regulation of glomerulus development is a complex and essential process that involves the coordinated interaction of multiple signaling pathways, transcription factors, and cell types. This process is crucial for ensuring the proper formation and function of the glomerulus, the filtering unit of the kidney. Disruptions to this process can lead to a variety of kidney diseases, highlighting the importance of understanding the molecular mechanisms that regulate glomerulus development.**'"

Proteins (1)

ProteinDefinitionTaxonomy
Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoformA protein phosphatase 3 catalytic subunit alpha that is encoded in the genome of human. [PRO:CNA, UniProtKB:Q08209]Homo sapiens (human)

Compounds (3)

CompoundDefinitionClassesRoles
tacrolimustacrolimus (anhydrous) : A macrolide lactam containing a 23-membered lactone ring, originally isolated from the fermentation broth of a Japanese soil sample that contained the bacteria Streptomyces tsukubaensis.

Tacrolimus: A macrolide isolated from the culture broth of a strain of Streptomyces tsukubaensis that has strong immunosuppressive activity in vivo and prevents the activation of T-lymphocytes in response to antigenic or mitogenic stimulation in vitro.
macrolide lactambacterial metabolite;
immunosuppressive agent
tamoxifenstilbenoid;
tertiary amino compound
angiogenesis inhibitor;
antineoplastic agent;
bone density conservation agent;
EC 1.2.3.1 (aldehyde oxidase) inhibitor;
EC 2.7.11.13 (protein kinase C) inhibitor;
estrogen antagonist;
estrogen receptor antagonist;
estrogen receptor modulator
cyclosporineramihyphin A: one of the metabolites produced by Fusarium sp. S-435; RN given refers to cpd with unknown MFhomodetic cyclic peptideanti-asthmatic drug;
anticoronaviral agent;
antifungal agent;
antirheumatic drug;
carcinogenic agent;
dermatologic drug;
EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor;
geroprotector;
immunosuppressive agent;
metabolite